AME - Educational Analysis * US Equities
Educational Analysis * US Equities

AME

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerAME
CategoryEducational primer
Last reviewedNovember 9, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

AMETEK, Inc. operates in the Industrials sector within the Electrical Equipment & Parts industry. The company is organized into two operating groups: Electronic Instruments (EIG), which makes advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets, and Electromechanical (EMG), which supplies precision motion control solutions, medical components and devices, thermal management systems, specialty metals and electrical interconnects. For the 2025 fiscal year AMETEK reported sales of $7,401.1 million and employed approximately 22,500 people.

The margin profile supports the idea that these are specialized, hard-to-replicate products. The company carries a 19.9% net margin and a 14.7% return on equity. Those figures are not accidental: test-and-measurement instrumentation, precision motion components and medical-grade engineered parts typically require deep application knowledge, long customer qualification cycles and embedded service relationships. A near-20% net margin suggests pricing power rather than commodity competition, while a mid-teens ROE indicates the company converts that pricing power into efficient returns for shareholders. The split between EIG and EMG also adds diversification, with EIG tilted toward analytical instruments and EMG weighted toward motion, thermal and interconnect technologies.

Financial posture

AMETEK currently trades at a market capitalization of $54.8 billion with a trailing P/E of 33.6. Against Industrials peers, a P/E above 30 generally signals the market is pricing in above-average earnings durability and growth, which fits a company that has compounded earnings through a mix of organic improvement and acquisitions. The 19.9% net margin and 14.7% ROE reinforce that interpretation: investors are not paying a premium for cyclical leverage alone; they are paying for a business that has delivered resilient profitability.

At the current snapshot the stock is priced at $239.14, with a 50-day exponential moving average of $242.92 and an RSI of 47.9. That RSI sits in neutral territory and the price is slightly below the 50-day EMA, suggesting the stock is neither overbought nor deeply oversold. The beta is 0.97, essentially market-neutral, which is consistent with a diversified industrial business whose mix of aerospace, medical, power and automation end markets tends to smooth out single-industry cyclicality.

Strategic priorities & outlook

AMETEK's most recent 10-K describes a repeatable growth playbook. The AMETEK Growth Model targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. Supporting that goal is an Operational Excellence program built on lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence.

Acquisitions are the other engine. From 2021 through December 31, 2025 AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone the company spent $933.2 million in cash, net of cash acquired, to purchase Kern, a provider of high-precision machining and optical inspection solutions, and FARO Technologies, a 3D measurement and imaging solutions company. Geographic expansion is also explicit: AMETEK maintains best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia, positioning operations close to customers and emerging-market demand. In 2025 the company delivered record operating income, net income, orders and backlog, with sales up 6.6% and diluted EPS up 7.9% to $6.40.

Macro & geopolitical exposure

As an Electrical Equipment & Parts business serving aerospace, defense, medical, automation, power and industrial process markets, AMETEK is exposed to several macro channels. Because roughly half of each segment's net sales go to customers outside the United States — 52% of EIG and 42% of EMG in 2025 — currency fluctuations are a meaningful variable. A stronger U.S. dollar compresses translated overseas revenue and earnings, while a weaker dollar has the opposite effect.

The industry also sits near the center of trade-policy risk. Precision instruments, specialty metals, electrical interconnects and motion-control components rely on global supply chains, and tariffs or export controls can affect both input costs and customer deliveries. Medical-device and aerospace customers bring regulatory exposure, including FDA oversight and aviation certification standards, which add long lead times but also create switching costs once products are qualified. Finally, capital spending in process industries and automation can slow during broader industrial downturns, while defense and medical spending tend to be more defensive. AMETEK's diversification across these end markets is therefore a meaningful feature of its risk profile.

Recent developments

The headlines around AMETEK as of early November 2026 center on earnings, capital return and management changes. On November 4, Zacks reported that AMETEK's Q3 earnings beat estimates on organic sales and margin gains. On November 6, the company declared its quarterly dividend. On November 9, AMETEK announced the promotions of John Henriques and Kevin Coleman to Senior Vice Presidents, according to PR Newswire. The same day, Zacks published an analysis putting AMETEK's international revenue trends in focus — a timely angle given that roughly half of each segment's sales are outside the U.S.

Earnings behavior & post-earnings drift

AMETEK has delivered an unusually consistent earnings record. Over the last eight reported quarters the company beat earnings estimates every time, for a 100% beat rate, with an average surprise of 4.3%. The average 5-day price move following those reports is 0.8% to the upside, which the dataset classifies as an "up" drift. That pattern is modest rather than dramatic: AMETEK tends to beat, and the stock tends to drift slightly higher over the week after the print, but the reaction is not explosive.

The most recent quarters show the nuance behind the average. On November 3, 2026 AMETEK reported EPS of $2.21 against a $2.11 estimate, a 4.7% beat, yet the stock fell 4.62% the next day and was flat over the following five days. The August 4, 2026 quarter showed a 5.0% surprise ($2.09 vs. $1.99), with the stock rising 0.28% the next day and 0.89% over five days. The April 30, 2026 quarter delivered a 3.7% beat ($1.97 vs. $1.90), but the next-day move was -2.13% and the five-day drift was -0.33%. The February 3, 2026 quarter produced a 3.6% surprise ($2.01 vs. $1.94), with a -0.48% next-day move but a 1.83% gain over the following week. The takeaway is that even flawless execution does not guarantee a positive immediate reaction; the market's real expectation can be embedded in the price ahead of the report, making post-earnings price action dependent on whether the beat clears an unofficial consensus that may already be higher than the published estimate.

AMETEK is scheduled to report next on February 2, 2027 before the market open, with a current consensus EPS estimate of $2.28. For readers seeking a deeper synthesis of institutional opinion around this earnings setup, the full institutional verdict on AMETEK is worth reviewing.

Frequently Asked Questions

What does AMETEK actually make?

AMETEK makes electronic instruments and electromechanical devices through two groups: Electronic Instruments (EIG) produces analytical, test and measurement instruments for process, aerospace, power and industrial markets; Electromechanical (EMG) supplies precision motion control, medical components, thermal management systems, specialty metals and electrical interconnects.

How strong are AMETEK's profitability metrics?

AMETEK reports a 19.9% net margin and a 14.7% return on equity, both supportive of a business with pricing power and efficient capital use. In fiscal 2025 sales rose 6.6% to $7,401.1 million and diluted EPS rose 7.9% to $6.40.

What is AMETEK's earnings track record?

Over the last eight reported quarters AMETEK beat earnings estimates every quarter, for a 100% beat rate and an average surprise of 4.3%. The average 5-day post-earnings price move across those quarters is 0.8% to the upside.

Real Data - Gamma QC Earnings IntelligenceAs of Nov 9, 2026
AMETEK, Inc. · Industrials / Electrical Equipment & Parts
$54.8BMarket cap
33.6P/E
19.9%Net margin
14.7%ROE
100%Beat rate, last 8Q
4.3%Avg EPS surprise
0.8%Avg 5-day move after earnings
2027-02-02Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-11-03$2.21$2.11+4.7%-4.62%null%
2026-08-04$2.09$1.99+5%+0.28%+0.89%
2026-04-30$1.97$1.9+3.7%-2.13%-0.33%
2026-02-03$2.01$1.94+3.6%-0.48%+1.83%
2025-10-30$1.89$1.76+7.4%--
2025-07-31$1.78$1.69+5.3%--

Previous AME editions

Beyond the primer

Get the institutional verdict on AME

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the AME verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.